Literatur
CAPRIRE Steering Committee (1996) A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet 348: 1329–1339
Bhatt DL, Cryer BL, Contant CF et al (2010) Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 363: 1909–1917
Stockl KM, Zakharyan A, Harada AS et al (2010) Risk of rehospitalisation for patients using cloipidogrel with a proton pump inhibitor. Arch Intern Med 170: 704–710
Kwok CS, LokeYK (2010) Meta-analysis: The effects of PPI on cadiavascular events and mortality in patients receiving clopidogrel. Aliment Pharmacol Ther 31: 810–823
Fischbach W, Darius H, Gross M et al (2010) Gleichzeitige Anwendung von Thrombozytenaggregationshemmern und Protonenpumpeninhibitoren. Positionspapier der DGVS und DKG. Z Gastroenterol 48: 1156–1163
Interessenkonflikt
Die Autorin gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Denzer, U. PPI-Prophylaxe für Risikopatienten unter Clopidogrel-Monotherapie reduziert das Ulkusrisiko. Gastroenterologe 6, 412–413 (2011). https://doi.org/10.1007/s11377-011-0573-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11377-011-0573-6